FDA — authorised 28 November 1969
- Marketing authorisation holder: ALLERGAN
- Status: approved
🇺🇸 Medrifar in United States
FDA authorised Medrifar on 28 November 1969
Marketing authorisations
FDA — authorised 28 November 1969
- Application: NDA016624
- Marketing authorisation holder: ALLERGAN
- Local brand name: HMS
- Indication: SUSPENSION — OPHTHALMIC
- Status: approved
Medrifar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Medrifar approved in United States?
Yes. FDA authorised it on 28 November 1969; FDA authorised it on 28 November 1969.
Who is the marketing authorisation holder for Medrifar in United States?
ALLERGAN holds the US marketing authorisation.